Novozymes A/S Stock Price, News & Analysis
Company Description
Novozymes A/S (OTC Link: NVZMY) is a publicly traded specialty chemicals company in the Basic Materials sector. The company has a market capitalization of $29.5B.
NVZMY stock has gained 10.9% over the past year. Shares last traded at $61.38.
This page provides a comprehensive overview of NVZMY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Novozymes A/S (NVZMY) stock last traded at $61.38, up 2.37% from the previous close. Over the past 12 months, the stock has gained 10.9%. At a market capitalization of $29.5B, NVZMY is classified as a large-cap stock with approximately 412.2M shares outstanding.
Latest News
Novozymes A/S has 3 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 0 with negative movement. Key topics include partnership. View all NVZMY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Novozymes A/S (NVZMY) currently stands at 405 shares, down 90.9% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 98.7%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Novozymes A/S (NVZMY) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
NVZMY Company Profile & Sector Positioning
Novozymes A/S (NVZMY) operates in the Specialty Chemicals industry within the broader Basic Materials sector and is listed on the OTC Link.
Investors comparing NVZMY often look at related companies in the same sector, including Novozymes (NVZMF), DSM-Firmenich (DSFIY), Givaudan (GVDBF), Symrise Ag (SYIEF), and Nitto Denko Adr (NDEKY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NVZMY's relative position within its industry.